Also trades as: ACI.BO (BSE) · $vol 0M
ACI.NS NSE
Archean Chemical Industries Limited
1W: -3.3%
1M: -3.6%
3M: -12.0%
YTD: -16.6%
1Y: -31.6%
3Y: -7.3%
₹462.10 ($4.80)
-12.95 (-2.73%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$10.8B
+3.8% ▲
5Y CAGR: +7.9%
Gross Profit
$7.2B
-31.3% ▼
5Y CAGR: +5.1%
Operating Income
$1.5B
-34.3% ▼
5Y CAGR: -5.6%
Net Income
$1.1B
-34.1% ▼
5Y CAGR: +9.9%
EPS (Diluted)
$8.65
-34.1% ▼
5Y CAGR: +6.0%
EBITDA
$2.5B
-20.6% ▼
5Y CAGR: -2.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $11.3B | $14.4B | $13.3B | $10.4B | $10.8B |
| YoY Growth | +53.0% | +27.4% | -7.6% | -21.7% | +3.8% |
| Cost of Revenue | $2.8B | $27M | $3.7B | -$78M | $3.6B |
| Gross Profit | $8.5B | $14.4B | $12.2B | $10.5B | $7.2B |
| Gross Margin | 75.3% | 99.8% | 91.4% | 100.7% | 66.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4.3B | $5.4B | $5.3B | $4.6B | $4.8B |
| Operating Expenses | $6.9B | $8.7B | $5.6B | $8.1B | $5.7B |
| Operating Income | $4.0B | $5.7B | $4.0B | $2.3B | $1.5B |
| Operating Margin | 35.8% | 39.3% | 30.4% | 22.6% | 14.3% |
| Interest Expense | $1.6B | $970M | $85M | $81M | $256M |
| Income Before Tax | $2.5B | $5.1B | $4.3B | $2.2B | $1.5B |
| Tax Expense | $628M | $1.3B | $1.1B | $616M | $417M |
| Net Income | $1.9B | $3.8B | $3.2B | $1.6B | $1.1B |
| Net Margin | 16.7% | 26.6% | 24.0% | 15.6% | 9.9% |
| EPS (Diluted) | $18.22 | $34.59 | $25.87 | $13.12 | $8.65 |
| EBITDA | $4.8B | $6.8B | $5.1B | $3.1B | $2.5B |
| Shares Outstanding | 103M | 111M | 123M | 124M | 124M |